Navigation Links
Anticoagulant does not reduce rate of ischemic events among certain patients undergoing PCI
Date:9/1/2013

countries between April 2010 and February 2013. Eligible participants were randomized to otamixaban or unfractionated heparin plus, at the time of PCI, eptifibatide.

The primary outcome of death or new myocardial infarction through day 7 occurred in 5.5 percent of the patients treated with otamixaban vs. 5.7 percent of the patients treated with UFH plus eptifibatide. Otamixaban did not significantly reduce the risk of any of the components of the primary outcomes, either death or heart attack, or of any of the secondary efficacy outcomes, including procedural thrombotic complications. Analysis of the primary outcome by 30 days confirmed the absence of a reduction with otamixaban.

In the lower-dose otamixaban group, discontinued by the data monitoring committee for futility based on the interim analysis, the rate of the primary outcome at day 7 was 6.3 percent.

Patients in the otamixaban group had about double the rate of the primary safety outcome of Thrombosis in Myocardial Infarction major or minor bleeding at day 7 compared with patients in the combination of UFH-plus-eptifibatide group (3.1 percent vs. 1.5 percent). Otamixaban consistently increased all types of bleeding events, regardless of the severity or bleeding classification scheme used. Study anticoagulant was discontinued because of bleeding in 242 patients (4.7 percent) in the otamixaban group and in 95 patients (1.7 percent) in the UFH-plus-eptifibatide group.

"Otamixaban did not reduce ischemic events compared with UFH plus eptifibatide but increased bleeding among patients with NSTE-ACS and a planned invasive strategy. These findings do not support the use of otamixaban for patients with NSTE-ACS undergoing planned early percutaneous coronary intervention," the authors conclude.


'/>"/>

Contact: Philippe Gabriel Steg, M.D.
gabriel.steg@bch.aphp.fr
The JAMA Network Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Huntingtons Disease Linked to Reduced Cancer Risk in Study
2. BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport
3. Decision guide reduced uncertainty over breast cancer prevention, study finds
4. Scoliosis Treatment Might Reduce Need for Surgeries
5. Exercise helps smokers to quit smoking, to remain smoke-free and to reduce the risk of death
6. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
7. Groundbreaking Nigeria summit results in major commitment to reduce child deaths
8. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
9. Use of dedicated pediatric imaging departments for pediatric CT reduces radiation dose
10. Automated breast ultrasound dramatically reduces physician interpretation time
11. Diabetic retinopathy research could reduce screening costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
(Date:1/22/2015)... January 22, 2015 Joan Lunden, award-winning ... speaker at the upcoming 32nd Annual Miami Breast ... Physicians’ Education Resource®, LLC (PER®) , shares that “a ... gone undetected if she had not followed up her ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
(Date:1/22/2015)... January 22, 2015 As interest in the ... care gains momentum worldwide, Rev. Eric J. Hall , ... Network (HCCN), will be the keynote speaker on January ... Israel’s public health system. , The conference, “Hope and Resilience: ...
(Date:1/22/2015)... Step into a macabre world where plants hold ... Wicked Plants, the Museum’s latest featured exhibition, opens Saturday, ... and diabolical plants inside of a dilapidated, Victorian home. ... physical and neurological processes between botanicals and the human ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... Devoted dog owners know,the dilemma -- my dog is old and ... I know when to let him go to the big dog ... Colorado fee-only financial planner, knows,the problem well. "A large number of ... vets when it,s time to say goodbye. In response,to the question: ...
... , News Facts , ... organization (CRO) based in Madrid,Spain, has deployed Oracle(R) Clinical applications to ... well as plans for continued,expansion in the global clinical trial market. ... manages approximately eight to 12 global clinical,trials annually and is involved ...
... of Toxic PVC Baby Products, Toys, & Other Products for Children ... CHURCH, Va., Nov. 24 A new guide released today ... consumers worried about toxic chemicals in toys, baby products, and the ... Poison Plastic -- the PVC-Free Guide for Your Family & Home ...
... Company with Greater Commercialization Capabilities, Expanded Portfolio of Pain Management Products ... King Extends Tender Offer Through December 19, 2008 , ... 24 King Pharmaceuticals, Inc. (NYSE: KG ) and ... two companies have signed a definitive merger agreement under which King ...
... Gift for Your Loved One , , ... find the perfect gift for a loved one with vision loss, ... Guide that contains gift ideas for game lovers, craft enthusiasts, movie ... list are all fully accessible and help people with low vision ...
... JOLLA, Calif., Nov. 24 Transdel,Pharmaceuticals, Inc. (OTC ... the development and commercialization of non-invasive,topically targeted medications, ... to the Company,s Board of Directors. , ... president of Swann, Inc., a consulting firm specializing ...
Cached Medicine News:Health News:Author Pens Pet Guardian Self-Defense Manual 2Health News:Sermes CRO Deploys Oracle(R) Clinical Applications to Support Growth 2Health News:Sermes CRO Deploys Oracle(R) Clinical Applications to Support Growth 3Health News:New Consumer Health Guide -- 'Pass Up the Poison Plastic, The PVC-Free Guide for Your Family & Home' Released Just in Time for the Holiday Shopping Season 2Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 2Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 3Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 4Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 5Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 6Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 7Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 8Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 9Health News:Ultimate Holiday Guide for Friends and Family of People with Vision Loss from the American Foundation for the Blind 2Health News:Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the President's Council on Physical Fitness and Sports, to Board of Directors 2Health News:Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the President's Council on Physical Fitness and Sports, to Board of Directors 3
(Date:1/22/2015)... 22, 2015  Bio-Techne Corporation (NASDAQ: TECH ) ... member of the new Simple Plex platform through its ... represents the re-branding of the previously acquired CyPlex instrument ... is a transformative immunoassay technology which integrates an innovatively ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/3h534b/infectious ) ... Diagnostics Market by Product, Application, Technology, End User - ... , The infectious disease diagnostics market is ... $18,156.2 million by 2019 from $12,422.8 million in 2014. ...
(Date:1/22/2015)... 2015 The Parenteral Drug Association (PDA) today announced the ... Enabling Pharmaceutical Manufacturing,s Future. The Manufacturing ... , Highlight the ongoing focus PDA has on pharmaceutical ... by filling known gaps in current manufacturing science as well ...
Breaking Medicine Technology:Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3PDA Launches Manufacturing Science Program(SM) 2PDA Launches Manufacturing Science Program(SM) 3
... BIOD ) will issue its second quarter fiscal year ... of the company,s financial results, Biodel,s senior management will host ... update on the company,s progress.May 10, 2012 schedule:6:00 am EDT: ... EDT: , Conference call participants should dial:+1 ( 877 ) ...
... Today, U.S. regulators and representatives from national food ... Use in Food Animal Production: Alternatives, Options and ... by the Alliance for the Prudent Use of ... promote judicious use of antibiotics, in order to ...
Cached Medicine Technology:National Stakeholders Meet To Consider Improvements In Antimicrobial Use In Food Animal Production 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: